| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9356 |
| Human Intestinal Absorption | HIA+ | 0.9566 |
| Caco-2 Permeability | Caco2- | 0.8283 |
| P-glycoprotein Substrate | Non-substrate | 0.7853 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9158 |
| Non-inhibitor | 0.9205 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8344 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4011 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7789 |
| CYP450 2D6 Substrate | Non-substrate | 0.8909 |
| CYP450 3A4 Substrate | Non-substrate | 0.7568 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8933 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7501 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9221 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6564 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7892 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8102 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9046 |
| Non-inhibitor | 0.9034 |
| AMES Toxicity | Non AMES toxic | 0.8408 |
| Carcinogens | Non-carcinogens | 0.8281 |
| Fish Toxicity | High FHMT | 0.7427 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5538 |
| Honey Bee Toxicity | Low HBT | 0.7989 |
| Biodegradation | Not ready biodegradable | 0.9902 |
| Acute Oral Toxicity | III | 0.7402 |
| Carcinogenicity (Three-class) | Non-required | 0.5665 |